RemSleep Holdings (RMSL) Liabilities and Shareholders Equity (2010 - 2025)
RemSleep Holdings recorded quarterly Liabilities and Shareholders Equity of $339756.0 in Q4 2025, down 26.79% quarter-over-quarter from $464065.0 in Q3 2025, and down 42.58% year-over-year from $591697.0 in Q4 2024.
RemSleep Holdings' Liabilities and Shareholders Equity history runs 16 years deep, the most recent figure standing at $339756.0 for Q4 2025.
- In Q4 2025, Liabilities and Shareholders Equity fell 42.58% year-over-year to $339756.0; the TTM figure through Dec 2025 stood at $2.0 million (down 46.24% YoY), while the FY2025 annual figure was $339756.0, down 42.58% from the prior year.
- Liabilities and Shareholders Equity came in at $339756.0 for Q4 2025 at RemSleep Holdings, down from $464065.0 in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $4.2 million in Q1 2022 to a low of $280123.0 in Q1 2021.
- A 5-year average of $1.8 million and a median of $1.2 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
- Across the five-year window, Liabilities and Shareholders Equity soared 1416.78% in 2021 and tumbled 64.28% in 2024, its largest moves.
- RemSleep Holdings' Liabilities and Shareholders Equity stood at $3.5 million in 2021, then retreated by 3.94% to $3.4 million in 2022, then tumbled by 64.11% to $1.2 million in 2023, then slumped by 50.95% to $591697.0 in 2024, then sank by 42.58% to $339756.0 in 2025.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $339756.0, $464065.0, and $541714.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 10.74 Bn |
| 10 | RemSleep Holdings | - | - | -7,636.00 | 339,756.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 339,756.00 |
| Sep 30, 2025 | 464,065.00 |
| Jun 30, 2025 | 541,714.00 |
| Mar 31, 2025 | 604,723.00 |
| Dec 31, 2024 | 591,697.00 |
| Sep 30, 2024 | 810,105.00 |
| Jun 30, 2024 | 1.07 Mn |
| Mar 31, 2024 | 1.16 Mn |
| Dec 31, 2023 | 1.21 Mn |
| Sep 30, 2023 | 2.27 Mn |
| Jun 30, 2023 | 2.55 Mn |
| Mar 31, 2023 | 2.99 Mn |
| Dec 31, 2022 | 3.36 Mn |
| Sep 30, 2022 | 3.77 Mn |
| Jun 30, 2022 | 4.13 Mn |
| Mar 31, 2022 | 4.21 Mn |
| Dec 31, 2021 | 3.50 Mn |
| Sep 30, 2021 | 2.49 Mn |
| Jun 30, 2021 | 464,245.00 |
| Mar 31, 2021 | 280,123.00 |
| Dec 31, 2020 | 230,662.00 |
| Sep 30, 2020 | 225,087.00 |
| Jun 30, 2020 | 173,356.00 |
| Mar 31, 2020 | 376,903.00 |
| Dec 31, 2019 | 253,297.00 |
| Sep 30, 2019 | 197,274.00 |
| Jun 30, 2019 | 273,041.00 |
| Mar 31, 2019 | 113,210.00 |
| Dec 31, 2018 | 57,076.00 |
| Sep 30, 2018 | 85,264.00 |
| Jun 30, 2018 | 244,438.00 |
| Mar 31, 2018 | 117,992.00 |
| Dec 31, 2017 | 183,782.00 |
| Sep 30, 2017 | 9,002.00 |
| Jun 30, 2017 | 19,577.00 |
| Mar 31, 2017 | 12,616.00 |
| Dec 31, 2016 | 12,845.00 |
| Sep 30, 2016 | 18,074.00 |
| Jun 30, 2016 | 18,315.00 |
| Mar 31, 2016 | 18,602.00 |
| Dec 31, 2015 | 18,870.00 |
| Sep 30, 2015 | 18,987.00 |
| Jun 30, 2015 | 19,217.00 |
| Mar 31, 2015 | 20,134.00 |
| Dec 31, 2014 | 18,024.00 |
| Sep 30, 2013 | -11.00 |
| Jun 30, 2013 | 158.00 |
| Mar 31, 2013 | 700.00 |
| Dec 31, 2012 | 478.00 |
| Sep 30, 2012 | 700.00 |
| Jun 30, 2012 | 29,441.00 |
| Mar 31, 2012 | 9,896.00 |
| Dec 31, 2011 | 12,359.00 |
| Sep 30, 2011 | 56,631.00 |
| Jun 30, 2011 | 10,750.00 |
| Dec 31, 2010 | 10,750.00 |